Antibacterial peptides and proteins with multiple cellular targets
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Native antimicrobial peptides and proteins represent bridges between innate and adaptive immunity in mammals. On the one hand they possess direct bacterial killing properties, partly by disintegrating bacterial membranes, and some also by inhibiting functions of intracellular biopolymers. On the other, native antimicrobial peptides and proteins upregulate the host defense as chemoattractants or by various additional immunostimulatory effects. Structure‐activity relationship studies indicate that residues responsible for the activities on bacterial membranes or for the secondary functions do not perfectly overlap. In reality, in spite of the relatively short size (18–20 amino acid residues) of some of these molecules, the functional domains can frequently be separated, with the cell‐penetrating fragments located at the C‐termini and the protein binding domains found upstream. As a cumulative effect, multifunctional and target‐specific (agonist or antagonist) antimicrobial peptides and proteins interfere with more than one bacterial function at low concentrations, eliminating toxicity concerns of the earlier generations of antibacterial peptides observed in the clinical setting. Copyright © 2005 European Peptide Society and John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829 · cited 1×
“Apparently many antimicrobial peptides are interfering with bacterial enzymatic processes, as much as the question was asked whether these molecules are pore formers or metabolic inhibitors in bacteria [24].”
Backgroundβ-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6
Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schröder, J. M., Wang, J. M., Howard, O. M. Z., et al. (1999) · Science · doi:10.1126/science.286.5439.525 · Cited by 1,809
Cathelicidins, multifunctional peptides of the innate immunity
Zanetti, M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403147 · Cited by 988 · cited 1×
“It was noted that despite their small size (the cathelicidin peptides LL-37 and PR-39, for instance, are, respectively, 37–and 39-amino acid residues) and their relatively simple structures, these peptides contain all the necessary information for exerting multiple and diverse actions, which in most cases require spec…”
BackgroundAgerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L., Kiessling, R., Jörnvall, H., Wigzell, H., & Gudmundsson, G. H. (2000) · Blood · doi:10.1182/blood.v96.9.3086 · Cited by 758
Mammalian defensins in immunity: more than just microbicidal
Yang, D., Biragyn, A., Kwak, L. W., & Oppenheim, J. J. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02246-9 · Cited by 696
Cathelicidins - a family of multifunctional antimicrobial peptides
Bals, R., & Wilson, J. M. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-2186-9 · Cited by 427 · cited 1×
“by a highly conserved cathepsin L inhibitor N-terminal signal sequence or proregion and a heterogeneous Cterminus that exhibits the bacterial killing properties [50].”
Background
Cited by
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
Antimicrobial Peptides: Successes, Challenges and Unanswered Questions
Wimley, W. C., & Hristova, K. (2011) · The Journal of Membrane Biology · doi:10.1007/s00232-011-9343-0 · Cited by 495
Pamp, S. J., Gjermansen, M., Johansen, H. K., & Tolker‐Nielsen, T. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06152.x · Cited by 486
Chemically modified and conjugated antimicrobial peptides against superbugs
Li, W., Separovic, F., O'Brien-Simpson, N. M., & Wade, J. D. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01026j · Cited by 439
Antimicrobial Peptides Targeting Gram-Positive Bacteria
Malanovic, N., & Lohner, K. (2016) · Pharmaceuticals · doi:10.3390/ph9030059 · Cited by 420
Lin, J., Zhou, D., Steitz, T. A., Polikanov, Y. S., & Gagnon, M. G. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-011942 · Cited by 405
Multifunctional host defense peptides: intracellular‐targeting antimicrobial peptides
Nicolas, P. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07359.x · Cited by 361
Reassessing the Host Defense Peptide Landscape
Haney, E. F., Straus, S. K., & Hancock, R. E. W. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00043 · Cited by 359
Antimicrobial Peptides: An Update on Classifications and Databases
Bin Hafeez, A., Jiang, X., Bergen, P. J., & Zhu, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111691 · Cited by 341
In Silico Models for Designing and Discovering Novel Anticancer Peptides
Tyagi, A., Kapoor, P., Kumar, R., Chaudhary, K., Gautam, A., & Raghava, G. P. S. (2013) · Scientific Reports · doi:10.1038/srep02984 · Cited by 320
Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?
Brogden, N. K., & Brogden, K. A. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.05.004 · Cited by 300
Analysis and prediction of antibacterial peptides
Lata, S., Sharma, B., & Raghava, G. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-263 · Cited by 296
Antimicrobial peptides with cell-penetrating peptide properties and vice versa
Splith, K., & Neundorf, I. (2011) · European Biophysics Journal · doi:10.1007/s00249-011-0682-7 · Cited by 265
Structural Studies on the Forward and Reverse Binding Modes of Peptides to the Chaperone DnaK
Zahn, M., Berthold, N., Kieslich, B., Knappe, D., Hoffmann, R., & Sträter, N. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.03.041 · Cited by 126
Amphibian antimicrobial peptides and Protozoa: Lessons from parasites
Rivas, L., Luque-Ortega, J. R., & Andreu, D. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.11.002 · Cited by 121
Discovery and development of a synthetic peptide derived from lactoferrin for clinical use
Brouwer, C. P. J. M., Rahman, M., & Welling, M. M. (2011) · Peptides · doi:10.1016/j.peptides.2011.07.017 · Cited by 90
“Besides their microbicidal activities AMP’s may play an important role in anti-tumor activity [93,123,141] bone repair [24], neoangiogenesis [115], enzymatic activity [64] and anti-biofilm activity [21].”
Background
Metadata
- Authors
- Otvos, L.
- Venue
- Journal of Peptide Science
- Publisher
- Wiley
- Published
- 2005-08
- Volume
- 11
- Issue
- 11
- Pages
- 697-706
- ISSN
- 1075-2617 (ISSN-L)
- 1099-1387
- OpenAlex
- W2023028104
- Cited by
- 157
- References
- 7
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.